“Biosimilar medicines: why the science behind them matters”: balanced and reassuring advice for healthcare providers

Producción científica: Contribución a una revista › Artículo › Investigación › revisión exhaustiva

Idioma original	Inglés
Páginas (desde-hasta)	134-135
Número de páginas	2
Publicación	Health Policy and Technology
Volumen	9
N.º	2
DOI	https://doi.org/10.1016/j.hlpt.2020.04.002
Estado	Publicada - jun 2020

Acceder al documento

@article{0c8c2f5d19b441818dcfa4ccb2e82373,

title = "“Biosimilar medicines: why the science behind them matters”: balanced and reassuring advice for healthcare providers",

author = "Mora, {Fernando de}",

year = "2020",

month = jun,

doi = "10.1016/j.hlpt.2020.04.002",

language = "English",

volume = "9",

pages = "134--135",

number = "2",

}

TY - JOUR

T1 - “Biosimilar medicines: why the science behind them matters”: balanced and reassuring advice for healthcare providers

AU - Mora, Fernando de

PY - 2020/6

Y1 - 2020/6

UR - http://www.scopus.com/inward/record.url?scp=85085014608&partnerID=8YFLogxK

UR - https://www.mendeley.com/catalogue/540ee159-5f7a-3999-a3ec-17c4d4a1a701/

U2 - 10.1016/j.hlpt.2020.04.002

DO - 10.1016/j.hlpt.2020.04.002

M3 - Article

SN - 2211-8837

VL - 9

SP - 134

EP - 135

JO - Health Policy and Technology

JF - Health Policy and Technology

IS - 2

ER -